Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes

NCT02762578 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

543

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec/insulin aspart
DRUG: biphasic insulin aspart

Sponsor

Novo Nordisk A/S